Now we know Warren Buffett's $1.8 billion secret

Berkshire Hathaway has finally disclosed its mystery stock purchases, revealing new stakes totaling $1.8 billion in steelmaker Nucor and homebuilders D.R. Horton and Lennar by the end of June, signaling a strategic focus on real assets and resilience. Concurrently, Berkshire also made a significant $1.6 billion investment in UnitedHealth, which saw its shares surge nearly 13% in premarket trading following the news. These targeted acquisitions occur as Berkshire continues its 11-quarter trend of being a net seller, strategically pruning positions while identifying specific value opportunities for long-term portfolio positioning.

Analysis

Berkshire Hathaway's latest 13F filing reveals a highly selective and strategic deployment of capital, despite the firm remaining a net seller for the 11th consecutive quarter. The long-awaited disclosure of its mystery investments unveiled new stakes in steelmaker Nucor and homebuilders D.R. Horton and Lennar, a combined $1.8 billion bet on real assets tied to infrastructure and housing, signaling a focus on resilience. Concurrently, Berkshire initiated a significant $1.6 billion position in UnitedHealth, a notable contrarian move given the insurer recently missed profit forecasts for the first time in a decade and faced stock pressure from leadership uncertainty and rising medical costs. The market immediately validated this confidence, with UnitedHealth shares surging nearly 13% in premarket trading. These targeted acquisitions, contrasted with the continued trimming of its flagship Apple holding, indicate a broader strategy of building a cash war chest while opportunistically investing in undervalued sectors, positioning the portfolio for long-term stability.

Key Decisions for Investors

• Investors should consider Berkshire's pivot to real assets via Nucor, D.R. Horton, and Lennar as a signal of potential long-term value and resilience in the housing and infrastructure sectors.
• The contrarian investment in UnitedHealth, and its subsequent price surge, highlights the opportunity in fundamentally sound companies that are temporarily out of favor, suggesting a re-evaluation of beaten-down names in the healthcare sector.
• Note that Berkshire remains a net seller and is trimming its Apple stake, which may warrant a review of exposure to mega-cap technology stocks and an increased focus on capital preservation.
• The strong market reaction to these disclosures underscores the continued influence of Berkshire's positioning, creating short-term trading opportunities in newly revealed holdings for those looking to follow institutional flows.